Biocon Biologics to Acquire Viatris Global Biosimilars Assets for upto USD 3.335 bn in stock & cash
Biocon Biologics: ensuring seamless care, to instill endless hope for cancer care.
World Cancer Day: We are committed to close the cancer care gap
Happy New Year 2022: As we enter the 2022, we renew our commitment to serve patients, enable equitable access & impact global health.
Biocon Biologics: Bringing A Paradigm Shift in Affordable Cancer Care!
Biocon Group takes pride in enabling its communities to participate in #HarGharTiranga Campaign.
Biocon Employees come together to sing our National Anthem to mark 75th Independence Day.